PRME — Prime Medicine Inc

Ownership history in DnB Asset Management AS  ·  1 quarter on record

This page tracks every 13F SEC filing in which DnB Asset Management AS reported a position in Prime Medicine Inc (PRME). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 INITIATED 182,133 — — 0.00% $1.0M $5.54
% of Fund (quarterly)    PRME price (monthly, adj. close)

Other funds also holding PRME

As of 2025 Q4 — sorted by position size

MWG Caph Ltd 8.59% Alphabet Inc. 3Y 2.23% Casdin Capital, LLC 3Y 7Y 0.68% Green Alpha Advisors, LLC 3Y 0.61% CHELSEA COUNSEL CO 3Y 7Y 0.34% Amova Asset Management Americas, Inc. 3Y 7Y 0.13% ARK Investment Management LLC 3Y 7Y 0.12% Greenwich Wealth Management LLC 3Y 7Y 0.11% IvyRock Asset Management (HK) Ltd 3Y 0.08% Palumbo Wealth Management LLC 3Y 0.07%
← Back to DnB Asset Management AS Holdings